Noramco, a US producer of active pharmaceutical ingredients (APIs), has announced the launch of Noramco Group as an integrated North American-based API and drug product supply chain services provider. The strategic alignment includes subsidiaries Purisys, Noramco, and the newly acquired drug product CDMO, Halo Pharma.
Britain's AstraZeneca is to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases, more than $1 billion.
US biotech company Antheia and Olon, an Italian producer of active pharmaceutical ingredients (APIs), have announced the continuation of their ongoing partnership to utilize Olon’s fermentation infrastructure for the scale-up and commercialization of Antheia’s early products.
US specialty materials producer Trinseo has commenced a sale process for its 50% ownership in Americas Styrenics (AmSty), a joint venture (JV) with Chevron Phillips Chemical.
Sasol has appointed Antje Gerber as executive vice president Chemicals and member of the group executive committee, effective April 15, 2024. She will succeed Brad Griffith, who is to retire on June 30, 2024.
US CDMO Adare Pharma Solutions is to add a high-shear mixer granulator at its Pessano, Italy facility, to complement existing fluid bed capabilities. The new mixer can provide wet granulation using either aqueous or organic-based solutions.
Japan-based pharmaceutical company Kyowa Kirin plans to build a $200 million biologics manufacturing center in Sanford, North Carolina, creating 102 jobs. This will be the company’s first North American pharmaceutical manufacturing operation, expected to create 102 jobs.
South Korea-based contract development and manufacturing organization (CDMO) SK Bioscience has broken ground on an approximately 4,200 m2 expansion of its L House vaccine manufacturing facility in Andong, Gyeongsangbuk-do, South Korea, which will serve as the production base for pneumococcal conjugate vaccine candidate GBP410, jointly developed by SK Bioscience and Sanofi, who are co-investing in the expansion.
In a move to expand its ophthalmic platform, Sandoz, the former generics and biosimilars arm of Swiss drugmaker Novartis, has completed the acquisition of Coherus BioSciences’ subsidiary Coherus Ophthalmology for $170 million.
AstraZeneca, whose CEO Pascal Soriot has been critical of the UK business environment for the life sciences industry in the past, wants to invest a large sum at its homebase. On Mar. 6, Chancellor Jeremy Hunt announced that the pharma giant plans to invest £650 million in the UK.
Swedish chemical producer Perstorp has bought out its minority partner in the joint venture (JV) Shandong Perstorp Chemical Co. (formerly Shandong Fufeng Perstorp Chemical Co.), which has owned and operated the site in China. Perstorp is now the sole owner of the polyol manufacturing operation, located in Zibo, Shandong province.
The pharmaceutical industry is a truly global and complex network of ingredients and materials suppliers, manufacturers, distributors for a variety of products ranging from vaccines to antibiotics and to therapeutic drugs for customers/patients.
AkzoNobel has completed a significant investment project at its production facility in Bac Ninh province, Vietnam, aimed at strengthening the company’s position in Asia and focusing on more sustainable manufacturing. The total investment amounts to €18.5 million.
Epsilogen and Lonza have successfully completed the manufacturing of a potential cancer treatment. The complex process, which took less than ten months, was carried out at Lonza’s UK site following Good Manufacturing Practice (GMP) standards.
Abu Dhabi National Oil Company (ADNOC) has completed the acquisition of a 24.9% stake in Austrian energy group OMV from Mubadala, the sovereign wealth fund of the United Arab Emirates. Financial details of the transaction, which was announced in December 2022, were not disclosed.
US biotechnology company Neomorph signed a $1.46 billion licensing agreement with Novo Nordisk to discover, develop and commercialize molecular glue degraders.
Bristol Myers Squibb (BMS) wants to invest $400 million for the construction and design of a sterile drug product (SDP) facility at its Cruiserath campus in Dublin, Ireland, significantly expanding manufacturing and laboratory capacity at the site.
Dutch paints and coatings group AkzoNobel has been opened a new €26 million manufacturing plant Faisalabad, Pakistan – the company’s largest investment in the country to date.
Unilever has appointed Heiko Schipper as President of the group’s Nutrition business, effective May 1, 2024.
Syngenta Group announced important collaborations following the launch of its innovation accelerator platform Shoots by Syngenta in 2023. These collaborations, which connect expertise across industries and sectors, are aimed at making possible novel solutions to agricultural challenges more quickly and efficiently.
ICL is to acquired Nitro 1000, a Brazilian manufacturer, developer and provider of biologicals for approximately $30 million.
Merck will open a new € 20 million distribution center in São Paulo, Brazil to better serve its Life Science customers in the region. The new space, which will be operational in late February, has an area of 13,000 square meters, which is twice as large as the former São Paulo location.
French industrial gases company Air Liquide and South African energy company Sasol have signed a power purchase agreements (PPAs) with Enel Green Power for the long term supply of an additional capacity of 110 MW of renewable power to Sasol’s Secunda site in South Africa.
Arkema has signed long term renewable energy agreements for its US sites in Calvert City, Kentucky, Beaumont, Texas, Chatham, Virginia, and West Chester, Pennsylvania, as well as for all Bostik sites in the United States. The company said that these agreements are part of its climate plan.
Within a few days, Anglo-Swedish drugmaker AstraZeneca has completed the acquisitions of Gracell Biotechnologies and Icosavax. Both transactions were announced in December 2023.
NextChem, part of Italian engineering group Maire Tecnimont, has signed a binding agreement to acquire 80% of HyDEP and 100% of Dragoni Group for a total of approximately €3.6 million.
As part of a multi-year agreement, US specialty chemicals company Albemarle will supply German car manufacturer BMW with battery-grade lithium for its electric vehicles (EVs), starting in 2025.
Sweden-based specialty chemicals company Perstorp has built and commissioned a new ISCC Plus-certified plant in western India to meet the growing market demand for Penta chemicals.
Olefins and polyolefins giant LyondellBasell (LYB) has acquired mechanical recycling assets containing rigid plastics recycling processing lines in the US from PreZero, a recycling and waste management service provider. The transaction, LYB said, includes the lease of the processing facility in Jurupa Valley, California, with a production capacity of approx. 23 million kg/year for recycled materials.
Evonik and the Johannes Gutenberg University Mainz (JGU) in Germany have signed a license agreement to commercialize randomized polyethylene glycols (rPEGs), a new class of PEGs.
Today, 73 industry leaders from 20 industrial sectors handed over "The Antwerp Declaration for a European Industrial Deal" to Belgian Prime Minister Alexander De Croo and Commission President Ursula von der Leyen. The declaration emphasizes industry's dedication to Europe's transformation and outlines urgent needs to enhance Europe's competitiveness, resilience, and sustainability amid challenging economic circumstances.
Norwegian energy group Equinor and India’s Deepak Fertilisers and Petrochemicals Corporation (DFPCL) have signed a 15-year contract for the supply of liquefied natural gas (LNG), scheduled to start in 2026.
The German start-up Bioweg found a way to replace petroleum-based chemicals with innovative bio-alternatives through fermentation and green chemistry. The processing of waste products results in bacterial cellulose, which serves as a substitute for synthetic polymers and thus has diverse potential applications.
In a move to improve the supply of renewable hydrogen and thus reduce dependence on natural gas and contribute to achieving the objectives of the European Green Deal and the REPowerEU plan, the EU Commission has approved a third Important project of common European interest (IPCEI) to support hydrogen infrastructure.
CEFIC, the European Chemical Industry Council, together with 25 other regional industry associations, has issued a joint statement calling on the European Union (EU) to realize the true potential of the single market.
